Gonorrhoea is one of the most common sexually transmitted diseases and has grown resistant to treatments over the years. A ...
On Friday, the F.D.A. approved a new antibiotic, zoliflodacin, a day after an article published in The Lancet reported that a ...
And GSK announced Thursday that the FDA had approved its medication gepotidacin, with the brand name Blujepa, as oral tablets ...
For the first time in nearly 40 years, the FDA approved a new antibiotic to treat gonorrhea, an STI that has grown ...
Thursday, the FDA addressed the shortfall with a label expansion for GSK’s Blujepa, which brings an oral option and a new ...
Global STD Diagnostics Market OverviewThe global STD diagnostics market is on a steady upward trajectory, projected to grow at a CAGR of 7–8% during the forecast period. This expansion is supported by ...
A romantic relationship that started on Tinder led to a civil jury trial in Hennepin County District Court that ended with ...
After a three-decade drought of new antibiotics to treat gonorrhea, the FDA has signed off on two first-in-class oral ...
China will soon start collecting a value-added tax on contraceptive drugs and products for the first time in over three ...
Phase 3 findings show oral zoliflodacin to be non-inferior to the combination of ceftriaxone and azithromycin for the ...
New data released by the National AIDS and STD Control Centre on the eve of World AIDS Day shows that only 77 percent of ...
China will soon start collecting a value-added tax on contraceptive drugs and products for the first time in over 30 years.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback